摘要: Approximately 5% of patients with malignant gliomas have a family history gliomas. Some these familial cases are associated rare genetic syndromes, such as neurofibromatosis types 1 and 2, the Li−Fraumeni syndrome (germ-line p53 mutations an increased risk several cancers), Turcot’s (intestinal polyposis brain tumors). 10 However, most
harvard.edu 
sci-hub.se 参考文章(190)
S. A. Wagner, A. Desjardins, D. A. Reardon, J. Marcello, J. E. Herndon, J. A. Quinn, J. N. Rich, S. Sathornsumetee, H. S. Friedman, J. J. Vredenburgh, Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas Journal of Clinical Oncology. ,vol. 26, pp. 2021- 2021 ,(2008) , 10.1200/JCO.2008.26.15_SUPPL.2021
Kenneth D. Aldape, Karla Ballman, Alfred Furth, Jan. C. Buckner, Caterina Giannini, Peter C. Burger, Bernd W. Scheithauer, Robert B. Jenkins, C. David James, Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. Journal of Neuropathology and Experimental Neurology. ,vol. 63, pp. 700- 707 ,(2004) , 10.1093/JNEN/63.7.700
Regina Fillbrandt, Katrin Lamszus, Ulrike Ulbricht, Philip Kunkel, Manfred Westphal, Dimitrios Stavrou, Marc A. Brockmann, Peter Bohlen, Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Research. ,vol. 61, pp. 6624- 6628 ,(2001)
K. Lamszus, P. Kunkel, M. Westphal, Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochirurgica. ,vol. 88, pp. 169- 177 ,(2003) , 10.1007/978-3-7091-6090-9_23
Rebecca A. Betensky, Andreas Von Deimling, J. Gregory Cairncross, Catherine L. Nutt, Todd R. Golub, Todd R. Golub, Ute Pohl, Peter M. Black, David N. Louis, Scott L. Pomeroy, Tracy T. Batchelor, Christine Ladd, Margaret E. McLaughlin, Pablo Tamayo, D. R. Mani, Christian Hartmann, Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Research. ,vol. 63, pp. 1602- 1607 ,(2003)
Andreas von Deimling, Jimmy T. Efird, John W. Henson, David N. Louis, Yasuhiro Ono, Keisuke Ueki, CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated Cancer Research. ,vol. 56, pp. 150- 153 ,(1996)
David N. Louis, WHO classification of tumours of the central nervous system International Agency for Research on Cancer. ,(2007)
Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason, Kurt A. Jaeckle, Athanassios P. Kyritsis, Michael D. Prados, Victor A. Levin, W.K. Alfred Yung, Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials Journal of Clinical Oncology. ,vol. 17, pp. 2572- 2578 ,(1999) , 10.1200/JCO.1999.17.8.2572
C A Meyers, M A Weitzner, A D Valentine, V A Levin, Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. Journal of Clinical Oncology. ,vol. 16, pp. 2522- 2527 ,(1998) , 10.1200/JCO.1998.16.7.2522
Steven S Brem, Philip J Bierman, Henry Brem, Nicholas Butowski, Marc C Chamberlain, Ennio A Chiocca, Lisa M DeAngelis, Robert A Fenstermaker, Allan Friedman, Mark R Gilbert, Deneen Hesser, Larry Junck, Gerald P Linette, Jay S Loeffler, Moshe H Maor, Madison Michael, Paul L Moots, Tara Morrison, Maciej Mrugala, Louis Burt Nabors, Herbert B Newton, Jana Portnow, Jeffrey J Raizer, Lawrence Recht, Dennis C Shrieve, Allen K Sills, Frank D Vrionis, Patrick Y Wen, Central Nervous System Cancers Journal of The National Comprehensive Cancer Network. ,vol. 11, pp. 1114- 1151 ,(2011) , 10.6004/JNCCN.2013.0132